Konstantinos Tsoumakas1,2, Konstantina Giamaiou2,3, Evgenios Goussetis3, Stelios Graphakos3, Athanasios Kossyvakis4, Elina Horefti4, Andreas Mentis4, Ioannis Elefsiniotis5, Ioanna D Pavlopoulou1,2. 1. Faculty of Nursing, Pediatric Clinic, "P & A Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece. 2. Pediatric Research Laboratory, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece. 3. Stem cell Transplant Unit, "Aghia Sophia" Children's Hospital, Athens, Greece. 4. Public Health Laboratories, Hellenic Pasteur Institute, Athens, Greece. 5. Department of Internal Medicine, Faculty of Nursing Athens, General and Oncology Hospital "Agii Anargyri", National and Kapodistrian University of Athens, Athens, Greece.
Abstract
BACKGROUND: Viral infections are a significant cause of morbidity and mortality in pediatric transplant populations. We analyzed the epidemiology of viral infections in pediatric hematopoietic stem cell transplant (HSCT) patients, including their incidence, associated risk factors, and outcome. METHODS: In a prospective study from September 2011 to September 2015, blood, urine, and stool specimens were monitored weekly from transplantation to day 100 or after if clinically suspected, by use of real-time polymerase chain reaction. Cytomegalovirus (CMV), Epstein-Barr virus (EBV), BK polyomavirus (BKV), Herpes simplex virus-1,2, Varicella zoster virus, Human herpes virus-6,7, and Adenovirus infections were monitored. All children and adolescents who underwent HSCT received long-term follow up in the regular outpatient clinics (range 2-48 months). RESULTS: A total of 192 HSCTs (autologous/allogeneic: 53/139) were performed in 165 subjects (median age: 5.6 years). Viruses most commonly isolated were CMV (46.1%), BKV (25.9%) and EBV (22.6%) and were more frequent in allogeneic versus autologous transplants (P < 0.05). Almost all high-risk allogeneic recipients developed EBV infections post-HSCT. EBV-PTLD was the only cause of death among those who developed viral disease. The factors significantly associated with the development of viral infections were recipient's advanced age, unrelated donor, mismatched graft and use of peripheral blood stem cells grafts. CONCLUSIONS: Viral infections were common among our pediatric recipients. Data suggest that monitoring of viral load may be significant to the prevention of viral disease. Particular demographic and transplantation characteristics were associated with the development of viral infections post-HSCT.
BACKGROUND:Viral infections are a significant cause of morbidity and mortality in pediatric transplant populations. We analyzed the epidemiology of viral infections in pediatric hematopoietic stem cell transplant (HSCT) patients, including their incidence, associated risk factors, and outcome. METHODS: In a prospective study from September 2011 to September 2015, blood, urine, and stool specimens were monitored weekly from transplantation to day 100 or after if clinically suspected, by use of real-time polymerase chain reaction. Cytomegalovirus (CMV), Epstein-Barr virus (EBV), BK polyomavirus (BKV), Herpes simplex virus-1,2, Varicella zoster virus, Human herpes virus-6,7, and Adenovirus infections were monitored. All children and adolescents who underwent HSCT received long-term follow up in the regular outpatient clinics (range 2-48 months). RESULTS: A total of 192 HSCTs (autologous/allogeneic: 53/139) were performed in 165 subjects (median age: 5.6 years). Viruses most commonly isolated were CMV (46.1%), BKV (25.9%) and EBV (22.6%) and were more frequent in allogeneic versus autologous transplants (P < 0.05). Almost all high-risk allogeneic recipients developed EBV infections post-HSCT. EBV-PTLD was the only cause of death among those who developed viral disease. The factors significantly associated with the development of viral infections were recipient's advanced age, unrelated donor, mismatched graft and use of peripheral blood stem cells grafts. CONCLUSIONS:Viral infections were common among our pediatric recipients. Data suggest that monitoring of viral load may be significant to the prevention of viral disease. Particular demographic and transplantation characteristics were associated with the development of viral infections post-HSCT.
Authors: Joyce Odeke Akello; Richard Kamgang; Maria Teresa Barbani; Franziska Suter-Riniker; Christoph Aebi; Christian Beuret; Daniel H Paris; Stephen L Leib; Alban Ramette Journal: Sci Rep Date: 2021-12-15 Impact factor: 4.379
Authors: Ndeye Soukeyna Diop; Pascal Roland Enok Bonong; Chantal Buteau; Michel Duval; Jacques Lacroix; Louise Laporte; Marisa Tucci; Nancy Robitaille; Philip C Spinella; Geoffrey Cuvelier; Suzanne M Vercauteren; Victor Lewis; Caroline Alfieri; Helen Trottier Journal: Vaccines (Basel) Date: 2021-06-07
Authors: Pascal Roland Enok Bonong; Monica Zahreddine; Chantal Buteau; Michel Duval; Louise Laporte; Jacques Lacroix; Caroline Alfieri; Helen Trottier Journal: Vaccines (Basel) Date: 2021-03-19
Authors: Sarah M Heston; Rebecca R Young; John S Tanaka; Kirsten Jenkins; Richard Vinesett; Frances M Saccoccio; Paul L Martin; Nelson J Chao; Matthew S Kelly Journal: Open Forum Infect Dis Date: 2021-12-16 Impact factor: 3.835